Insulet Corp (STU:GOV)
€ 228.1 5 (2.24%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 93/100

Insulet Corp at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 12, 2021 / 08:00PM GMT
Release Date Price: €237.5 (+2.68%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Okay. Great. I see we got Eric and Bret. Waiting for Deb there. Can you guys hear us okay?

Bret Christensen
Insulet Corporation - Executive VP & Chief Commercial Officer

Yes. We can hear you fine, Matt. I think Deb was going to join as participant and wasn't going to be in this panel forâ¦

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Oh, okay. My bad. Okay. So why don't we get started? I can introduce everybody.

So this panel is going to be a 45-minute fireside chat with Insulet. This is -- both -- if you look on the left-hand side, Eric Benjamin, Senior VP of Innovation and Strategy. We also have Bret Christensen, EVP and CCO of the company. So really appreciate you guys joining us, and it's a unique opportunity. We always get to talk to you guys, so I'm really looking forward to it.

As always

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot